Abstract subject matter can comprise recent research, clinical projects, or alternatively a case series or individual case report involving any aspect of equine veterinary science. The abstracts need to be informative, and such statements as “…results will be presented…” are unacceptable. All of the information to be presented must be included in the abstract. Any advertisements for commercial products must not be included, however, it is acceptable to mention registered drug names and dose rates if they are critical to the information presented. You are reminded that abstracts should not contain citations to published literature. Clinical papers that have previously been presented in Australasia or published in a peer-reviewed journal are unlikely to be considered for inclusion, and a declaration to previous presentation and/or publication must be included on the submission form. Please note that accepted abstracts will be printed in the Spring 2026 AEV Journal and may appear in other EVA media.

Submitted abstracts will have their authorship blinded and be peer-reviewed by a panel appointed by both EVA and the Equine chapter of the ANZCVS. A submission form should accompany every abstract. Multiple abstracts can be submitted by the same author/s. To assist with the blinding process please submit two copies of the abstract, both as Word documents; one with authorship clearly stated and the other blinded with the names of author(s) and clinic/company/organisation removed. All identifying comments should also be removed from the body of the abstract.

The abstract should be in the following format and should be a maximum of one A4 page. It is the author’s responsibility to ensure they do not exceed the abstract word limit of 250 words. If the abstract is not written in the correct format authors may be given the opportunity to resubmit. Applicants will be notified by email if your abstract has been accepted. Successful abstracts will be presented at the 2026 Bain Fallon Memorial Lectures, Monday 20 July, at the Pullman Albert Park, Melbourne, with a number of prizes on offer.

1. Title (top line): bolded, centred, all letters capitalised/upper case.

2.  Authors and affiliations: centred; 2nd line: names of authors with presenting author underlined. 3rd line: presenter’s clinic/company/organisation. 

3. Introduction

4. Materials and methods, or Case history (including any diagnostic tests/techniques and Animal Ethics Approval numbers for research papers)

5. Results, or Clinical outcome

6. Relevance to Australian clinical equine practice (a paragraph on each of the items 3 to 6 should suffice) 
    

In 2026, Lightning talks will be introduced at the EVA Bain Fallon Memorial Lectures. This initiative is in response to attendee feedback requesting greater clinical relevance and broader discussion within abstract presentations, without diluting the opportunity for presentation of research projects by Australian research groups. 

All abstract submission will be reviewed by four independent judges. Following grading, the highest ranked submissions will be selected for standard abstract presentations, with the next highest scoring submissions offered Lightning talks. Applicants offered a Lightning talk who choose not to accept will subsequently be offered the opportunity to present their material during the Poster session.
 

 

Lightning talks are very short presentations on case-based or research topics with strong clinical value to the equine veterinary community. Given they are short, they should contain very directed information. The goal of Lightning talks is to provide increased opportunity for dissemination of interesting information that furthers knowledge within our equine veterinary community whilst maximising audience engagement.

 

Think of a Lightning talk like an ‘elevator pitch’: concise, engaging, and focused, with just enough detail to clearly communicate the key message. The aim is to capture and maintain audience interest while highlighting your most important clinical or research insights. The talk has minimal introduction, but still needs to set the scene, and needs to be snappy, specifically outlining the important points of your case/s or research. If you have a large project/topic then talk about one interesting aspect of the project/topic.

Overall, there needs to be emphasis on the objective and outcome of the case/research. The presentation needs to be 3 slides maximum (not including the title page/conflict of interest slide):

1.Background/intro,
2. Methods/what you did,
3. Outcome and clinical relevance (results and practical take-home message). 

There is a strict 4-minute running time for your talk. It is important to practice your talk so you adhere to the allocated time. A warning bell will sound at 3 minutes, then a final bell at 4 minutes. There will be no questions during the allocated time but there will be time for questions to be directed at the entire pool of presenters at the end of the session.